Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans.

Müller U, Stenzel W, Köhler G, Werner C, Polte T, Hansen G, Schütze N, Straubinger RK, Blessing M, McKenzie AN, Brombacher F, Alber G.

J Immunol. 2007 Oct 15;179(8):5367-77.

2.

Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans.

Arora S, Olszewski MA, Tsang TM, McDonald RA, Toews GB, Huffnagle GB.

Infect Immun. 2011 May;79(5):1915-26. doi: 10.1128/IAI.01270-10. Epub 2011 Mar 7.

3.

Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.

Hardison SE, Wozniak KL, Kolls JK, Wormley FL Jr.

Infect Immun. 2010 Dec;78(12):5341-51. doi: 10.1128/IAI.00845-10. Epub 2010 Oct 4.

4.

Abrogation of IL-4 receptor-α-dependent alternatively activated macrophages is sufficient to confer resistance against pulmonary cryptococcosis despite an ongoing T(h)2 response.

Müller U, Stenzel W, Piehler D, Grahnert A, Protschka M, Köhler G, Frey O, Held J, Richter T, Eschke M, Kamradt T, Brombacher F, Alber G.

Int Immunol. 2013 Aug;25(8):459-70. doi: 10.1093/intimm/dxt003. Epub 2013 Mar 26.

PMID:
23532373
5.

STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.

Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Wormley FL Jr.

J Immunol. 2014 Oct 15;193(8):4060-71. doi: 10.4049/jimmunol.1400318. Epub 2014 Sep 8.

6.
7.

Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans.

Nakamura Y, Sato K, Yamamoto H, Matsumura K, Matsumoto I, Nomura T, Miyasaka T, Ishii K, Kanno E, Tachi M, Yamasaki S, Saijo S, Iwakura Y, Kawakami K.

Infect Immun. 2015 Feb;83(2):671-81. doi: 10.1128/IAI.02835-14. Epub 2014 Nov 24.

8.
9.

Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.

Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, Wormley FL Jr.

Am J Pathol. 2010 Feb;176(2):774-85. doi: 10.2353/ajpath.2010.090634. Epub 2010 Jan 7.

10.

Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection.

Jain AV, Zhang Y, Fields WB, McNamara DA, Choe MY, Chen GH, Erb-Downward J, Osterholzer JJ, Toews GB, Huffnagle GB, Olszewski MA.

Infect Immun. 2009 Dec;77(12):5389-99. doi: 10.1128/IAI.00809-09. Epub 2009 Sep 14.

11.

Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.

Guillot L, Carroll SF, Homer R, Qureshi ST.

Infect Immun. 2008 Oct;76(10):4745-56. doi: 10.1128/IAI.00341-08. Epub 2008 Aug 4.

12.

Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.

Wozniak KL, Ravi S, Macias S, Young ML, Olszewski MA, Steele C, Wormley FL.

PLoS One. 2009 Sep 3;4(9):e6854. doi: 10.1371/journal.pone.0006854.

13.

Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.

Hardison SE, Herrera G, Young ML, Hole CR, Wozniak KL, Wormley FL Jr.

J Immunol. 2012 Oct 15;189(8):4060-8. doi: 10.4049/jimmunol.1103455. Epub 2012 Sep 14.

14.

IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms.

Szymczak WA, Sellers RS, Pirofski LA.

Am J Pathol. 2012 Apr;180(4):1547-59. doi: 10.1016/j.ajpath.2011.12.038. Epub 2012 Feb 16.

15.
16.

Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis.

Arora S, Hernandez Y, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB.

J Immunol. 2005 May 15;174(10):6346-56.

17.

Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99.

Zhang Y, Wang F, Tompkins KC, McNamara A, Jain AV, Moore BB, Toews GB, Huffnagle GB, Olszewski MA.

Am J Pathol. 2009 Dec;175(6):2489-500. doi: 10.2353/ajpath.2009.090530. Epub 2009 Nov 5.

18.

Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide.

Rivera J, Mukherjee J, Weiss LM, Casadevall A.

J Immunol. 2002 Apr 1;168(7):3419-27.

19.

Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism.

Tang C, Inman MD, van Rooijen N, Yang P, Shen H, Matsumoto K, O'Byrne PM.

J Immunol. 2001 Feb 1;166(3):1471-81.

20.

Role of IL-17A on resolution of pulmonary C. neoformans infection.

Wozniak KL, Hardison SE, Kolls JK, Wormley FL.

PLoS One. 2011 Feb 17;6(2):e17204. doi: 10.1371/journal.pone.0017204.

Supplemental Content

Support Center